These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9831304)

  • 1. Naltrexone effects on insulin sensitivity and insulin secretion in hyperandrogenic women.
    Sir-Petermann T; López G; Castillo T; Calvillán M; Rabenbauer B; Wildt L
    Exp Clin Endocrinol Diabetes; 1998; 106(5):389-94. PubMed ID: 9831304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone, insulin-like growth factor-I axis, and insulin secretion in hyperandrogenic adolescents.
    Ibáñez L; Potau N; Georgopoulos N; Prat N; Gussinyé M; Carrascosa A
    Fertil Steril; 1995 Dec; 64(6):1113-9. PubMed ID: 7589662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients.
    Villa P; Fulghesu AM; De Marinis L; Valle D; Mancini A; Pavone V; Caruso A; Lanzone A
    Metabolism; 1997 May; 46(5):538-43. PubMed ID: 9160821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women.
    Azziz R; Bradley EL; Potter HD; Parker CR; Boots LR
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1251-6. PubMed ID: 7726265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
    Falcone T; Finegood DT; Fantus IG; Morris D
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1653-7. PubMed ID: 2146285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of opioid blockade on insulin metabolism in polycystic ovarian disease.
    Fulghesu AM; Ciampelli M; Fortini A; Cucinelli F; Guido M; Caruso A; Lanzone A; Mancuso S
    Hum Reprod; 1995 Sep; 10(9):2253-7. PubMed ID: 8530646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome.
    Guido M; Pavone V; Ciampelli M; Murgia F; Fulghesu AM; Apa R; Caruso A; Mancuso S; Lanzone A
    J Clin Endocrinol Metab; 1998 May; 83(5):1742-5. PubMed ID: 9589685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study.
    Cucinelli F; Soranna L; Perri C; Barini A; Cento RM; Mancuso S; Lanzone A
    Fertil Steril; 2004 Apr; 81(4):1047-54. PubMed ID: 15066462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
    Damjanovic SS; Lalic NM; Pesko PM; Petakov MS; Jotic A; Miljic D; Lalic KS; Lukic L; Djurovic M; Djukic VB
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease.
    Fulghesu AM; Ciampelli M; Guido M; Murgia F; Caruso A; Mancuso S; Lanzone A
    Metabolism; 1998 Feb; 47(2):158-62. PubMed ID: 9472963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of naltrexone treatment on insulin secretion, insulin action and postprandial thermogenesis in obesity.
    Vettor R; Macor C; Rossi E; De Palo C; Ruggeri A; Cobelli C; Federspil G
    Horm Metab Res; 1994 Apr; 26(4):188-94. PubMed ID: 8082873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism.
    Ibanez L; Potau N; Zampolli M; Prat N; Virdis R; Vicens-Calvet E; Carrascosa A
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1237-43. PubMed ID: 8772605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism.
    Karjalainen A; Paassilta M; Heikkinen J; Bäckström AC; Savolainen M; Kesäniemi YA
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):165-73. PubMed ID: 11207630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.
    Rosenfalck AM; Maghsoudi S; Fisker S; Jørgensen JO; Christiansen JS; Hilsted J; Vølund AA; Madsbad S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4173-81. PubMed ID: 11095450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
    Pawelczyk L; Spaczynski RZ; Banaszewska B; Duleba AJ
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):209-13. PubMed ID: 15063962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome.
    Cupisti S; Kajaia N; Dittrich R; Duezenli H; W Beckmann M; Mueller A
    Eur J Endocrinol; 2008 May; 158(5):711-9. PubMed ID: 18426831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women.
    Basu R; Dalla Man C; Campioni M; Basu A; Nair KS; Jensen MD; Khosla S; Klee G; Toffolo G; Cobelli C; Rizza RA
    Diabetes; 2007 Mar; 56(3):753-66. PubMed ID: 17327446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.
    Nader S; Riad-Gabriel MG; Saad MF
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3074-7. PubMed ID: 9284746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hormonal phenotype of Nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency.
    Carbunaru G; Prasad P; Scoccia B; Shea P; Hopwood N; Ziai F; Chang YT; Myers SE; Mason JI; Pang S
    J Clin Endocrinol Metab; 2004 Feb; 89(2):783-94. PubMed ID: 14764797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.